Tools
Tools
Sarmah, Piyush Bhargav, Ehsanullah, Syed Ali and Sarmah, Bhupendra Dev Long-term follow-up and outcomes of percutaneous nephron-sparing surgery for upper tract urothelial carcinoma. Indian journal of urology : IJU : journal of the Urological Society of India, 36 (4). pp. 276-281. ISSN 0970-1591. Available through UHB Open Athens
Full text not available from this repository.Abstract
Introduction
Upper tract urothelial carcinoma (UTUC) is uncommon, accounting for 5%-10% of all urothelial carcinomas. Current standard of care for localized disease consists of radical nephroureterectomy (RNU) which leads to loss of half the patient's functioning nephrons. Percutaneous nephron-sparing surgery (PCNSS) is an alternative minimally-invasive approach in selected cases where nephron preservation is desired. The long-term outcomes of this procedure at a single center are described.
Methods
All patients undergoing PCNSS, with the operation carried out by a single surgeon, were included. Equipment used was a standard 26Ch resectoscope through a 30Ch Amplatz sheath, with all patients receiving postoperative intrapelvic Mitomycin. Data for each patient were collected on patient age; tumor size at diagnosis; grade; stage; oncological recurrence; requirement for subsequent RNU; and overall survival. Primary outcomes were disease recurrence and overall mortality, and secondary outcome was rate of subsequent RNU.
Results
Fifteen patients in total underwent PCNSS, 14 were diagnosed with UTUC; benign leiomyoma was proven in one patient and excluded from final analysis. Overall survival at 5 and 10 years was 92.9% and 78.6%, respectively, with disease-specific mortality at 10 years of 7.1% (one patient who developed metastatic carcinoma); 21.4% of patients had recurrent ipsilateral UTUC and all required subsequent RNU for this indication. No patients had seeding of the percutaneous tract.
Conclusion
PCNSS for UTUC is a feasible approach to consider in carefully selected patients who agree to intensive follow-up, even for higher grade tumors. Where recurrent UTUC occurs, further management options still exist for disease treatment.
| Item Type: | Article |
|---|---|
| Additional Information: | Available through UHB Open Athens |
| Subjects: | WJ Urogenital system. Urology |
| Divisions: | Planned IP Care > Urology |
| Related URLs: | |
| Depositing User: | Beth Connors |
| Date Deposited: | 04 Jan 2021 15:50 |
| Last Modified: | 04 Jan 2021 15:50 |
| URI: | http://www.repository.uhblibrary.co.uk/id/eprint/3796 |
Actions (login required)
 |
View Item |
